Prostate cancer immunology - an update for Urologists (Q37808756)

23 August 2017

Prostate cancer immunology - an update for Urologists (English)

1 reference

23 August 2017

0 references

1 reference

2

0 references

Laurence Klotz

4

object named as

Laurence Klotz

1 reference

23 August 2017

Nieroshan Rajarubendra

1

1 reference

PubMed ID

21070575

23 August 2017

Damien M Bolton

3

1 reference

PubMed ID

21070575

23 August 2017

Ian D Davis

5

1 reference

23 August 2017

10 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

107

1 reference

23 August 2017

7

1 reference

23 August 2017

1046-1051

1 reference

Epidemiologic association between prostatitis and prostate cancer

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Inflammation, infection, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

RETRACTED: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

21 January 2018

A short history of HLA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

The role of nitric oxide in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Immune therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Prostate cancer vaccines: current status and future potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09820.X

10.1111/J.1464-410X.2010.09820.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21070575